XML 71 R64.htm IDEA: XBRL DOCUMENT
v3.24.3

Acquisitions - Estimated Useful Life and Fair Value (Detail) - USD ($) $ in Thousands | 12 Months Ended
--- | ---
Dec. 31, 2023 | Dec. 31, 2022
Metenova Holding AB |  |
Fair Value | $ 58,762 |
FlexBiosys, Inc. |  |
Fair Value | $ 12,640 |
BioFlex And NTM Acquisition |  |
Fair Value |  | $ 17,150
Avitide, Inc. |  |
Fair Value |  | 46,650
Polymem S.A. |  |
Fair Value |  | $ 9,096
Customer Relationships [Member] | Metenova Holding AB |  |
Weighted Average Useful Life (in years) | 15 years |
Fair Value | $ 12,659 |
Customer Relationships [Member] | FlexBiosys, Inc. |  |
Weighted Average Useful Life (in years) | 12 years |
Fair Value | $ 2,530 |
Customer Relationships [Member] | BioFlex And NTM Acquisition |  |
Weighted Average Useful Life (in years) |  | 10 years
Fair Value |  | $ 13,240
Customer Relationships [Member] | Avitide, Inc. |  |
Weighted Average Useful Life (in years) |  | 13 years
Fair Value |  | $ 24,580
Developed Technology Rights [Member] | Metenova Holding AB |  |
Weighted Average Useful Life (in years) | 15 years |
Fair Value | $ 44,377 |
Developed Technology Rights [Member] | FlexBiosys, Inc. |  |
Weighted Average Useful Life (in years) | 16 years |
Fair Value | $ 9,860 |
Developed Technology Rights [Member] | BioFlex And NTM Acquisition |  |
Weighted Average Useful Life (in years) |  | 11 years
Fair Value |  | $ 3,540
Developed Technology Rights [Member] | Avitide, Inc. |  |
Weighted Average Useful Life (in years) |  | 15 years
Fair Value |  | $ 20,650
Developed Technology Rights [Member] | Polymem S.A. |  |
Weighted Average Useful Life (in years) |  | 13 years
Fair Value |  | $ 8,274
Trademark and tradename [Member] | Metenova Holding AB |  |
Weighted Average Useful Life (in years) | 15 years |
Fair Value | $ 939 |
Trademark and tradename [Member] | FlexBiosys, Inc. |  |
Weighted Average Useful Life (in years) | 4 years |
Fair Value | $ 30 |
Trademark and tradename [Member] | BioFlex And NTM Acquisition |  |
Weighted Average Useful Life (in years) |  | 15 years
Fair Value |  | $ 310
Trademark and tradename [Member] | Avitide, Inc. |  |
Weighted Average Useful Life (in years) |  | 18 years
Fair Value |  | $ 1,210
Trademark and tradename [Member] | Polymem S.A. |  |
Weighted Average Useful Life (in years) |  | 14 years
Fair Value |  | $ 510
Noncompete Agreements [Member] | Metenova Holding AB |  |
Weighted Average Useful Life (in years) | 2 years |
Fair Value | $ 787 |
Noncompete Agreements [Member] | FlexBiosys, Inc. |  |
Weighted Average Useful Life (in years) | 5 years |
Fair Value | $ 220 |
Noncompete Agreements [Member] | BioFlex And NTM Acquisition |  |
Weighted Average Useful Life (in years) |  | 3 years
Fair Value |  | $ 60
Noncompete Agreements [Member] | Avitide, Inc. |  |
Weighted Average Useful Life (in years) |  | 3 years
Fair Value |  | $ 210
Noncompete Agreements [Member] | Polymem S.A. |  |
Weighted Average Useful Life (in years) |  | 5 years
Fair Value |  | $ 312

X
- Definition Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 985 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2 + Details
Name: | us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of identifiable intangible assets recognized as of the acquisition date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 55 -Paragraph 37 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479303/805-10-55-37 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=rgen_MetenovaHoldingAbMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=rgen_FlexbiosysIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=rgen_BioflexAndNtmAcquisitionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=rgen_AvitideIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=rgen_PolymemSAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |